Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Smart Medicine|May 20, 2025
The Recent Development in the Diagnosis of <i>Mycobacterium tuberculosis</i>Nimet Temur, Esma Eryilmaz- Eren, Ilhami Celik, et al.
Plos One|September 16, 2020
Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in TurkeyShaikh Terkis Islam Pavel, Hazel Yetiskin, Gunsu Aydin, et al.
International Journal of Clinical Practice|October 29, 2021
Low-dose tocilizumab is associated with improved outcome and a low risk of secondary infection in severe COVID-19 pneumoniaIlhami Celik, Esma Eryilmaz-Eren, Aysin Kilinc-Toker, et al.
Natural Product Research|October 16, 2019
A new polyketide from the bark of <i>Hypericum roeperianum</i> Schimp. (Hypericaceae)François Damen, Olive Monique F Demgne, Gabin Thierry M Bitchagno, et al.
Natural Product Research|April 24, 2018
Guttiferone BL with antibacterial activity from the fruits of <i>Allanblackia gabonensis</i>Blaise Kemajou Nganou, Ingrid Simo Konga, Aimé G Fankam, et al.
Vaccines|February 26, 2025
Efficacy of Inactivated Bivalent SARS-CoV-2 Vaccines Targeting Ancestral Strain (ERAGEM), Delta, and Omicron VariantsBusra Kaplan, Shaikh Terkis Islam Pavel, Muhammet Ali Uygut, et al.
African Health Sciences|April 7, 2025
Risk factors for invasive mold infection after COVID-19: case-control studyEsma Eryilmaz-Eren, Hafize Sav, Zuhal Ozer-Simsek, et al.
Human Vaccines & Immunotherapeutics|June 26, 2024
The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac -inactivated COVID-19 vaccinesMine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, et al.
Vaccines|November 11, 2022
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III TrialMine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
Antibacterial Activity of Extract, Fractions, and Compounds from <i>Termitomyces clypeatus</i> R. Heim (Lyophyllaceae) Against Multidrug-Resistant Bacteria Overexpressing Efflux PumpsJenifer R N Kuete, Jason B T Kuete, Joris Baier, et al.
Pageof 6